AdaptHealth Corp. (AHCO)
| Market Cap | 1.45B +13.9% |
| Revenue (ttm) | 3.29B +1.2% |
| Net Income | -79.63M |
| EPS | -0.59 |
| Shares Out | 133.12M |
| PE Ratio | n/a |
| Forward PE | 10.80 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 120,547 |
| Open | 10.66 |
| Previous Close | 10.76 |
| Day's Range | 10.66 - 11.00 |
| 52-Week Range | 8.51 - 13.43 |
| Beta | 1.45 |
| Analysts | Strong Buy |
| Price Target | 14.14 (+29.84%) |
| Earnings Date | Aug 4, 2026 |
About AHCO
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for AHCO stock is "Strong Buy." The 12-month stock price target is $14.14, which is an increase of 29.84% from the latest price.
News
AdaptHealth upgraded to Buy at Jefferies on improved growth, earnings visibility
As previously reported, Jefferies upgraded AdaptHealth (AHCO) to Buy from Hold with a price target of $13, up from $11. With its underperforming diabetes business divested, just as the core…
AdaptHealth upgraded to Buy from Hold at Jefferies
Jefferies upgraded AdaptHealth (AHCO) to Buy from Hold with a price target of $13, up from $11.
Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million
Cardinal Health said on Monday it has agreed to buy AdaptHealth's diabetes health business and medical supply provider Strive Medical in separate deals for about $360 million in total, expanding its...
Cardinal to acquire Diabetes business of AdaptHealth, Strive Medical for $360M
Cardinal Health (CAH) announced it has entered into two definitive agreements. Cardinal Health will acquire the Diabetes Health business of AdaptHealth (AHCO), and, in its entirety, Strive Medical, a ...
Cardinal Health expands home care business with two tuck-in acquisitions
DUBLIN, Ohio, July 20, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy. Cardinal H...
AdaptHealth to divest diabetes health business to Cardinal Health for $235M
AdaptHealth Corp. (AHCO) that it is divesting its Diabetes Health business to Cardinal Health (CAH). Under the terms of an agreement signed July 19, 2026, Cardinal Health will acquire AdaptHealth’s…
AdaptHealth Corp. Enters into Definitive Agreement to Divest Diabetes Health Business to Cardinal Health
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Call
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth price target lowered to $15 from $18 at Baird
Baird lowered the firm’s price target on AdaptHealth (AHCO) to $15 from $18 and keeps an Outperform rating on the shares. The firm updated its model following its recent cyberattack…
AdaptHealth investigating security incident
In a regulatory filing, AdaptHealth (AHCO) Corp. disclosed that the company is investigating a security incident whereby a threat actor gained unauthorized access to company systems and exfiltrated ce...
AdaptHealth Transcript: AGM 2026
The meeting covered director elections, auditor ratification, and executive compensation, with all proposals passing by strong majorities. Quorum was achieved, and no relevant questions were raised during the Q&A session.
AdaptHealth Transcript: Bank of America Global Healthcare Conference 2026
All business segments grew organically in Q1, with a major new capitated contract driving revenue and expected to reach a 20% margin by 2026. Investments in infrastructure and technology are improving efficiency, while regulatory changes and disciplined M&A support future growth.
AdaptHealth price target raised to $15 from $13 at RBC Capital
RBC Capital raised the firm’s price target on AdaptHealth (AHCO) to $15 from $13 and keeps an Outperform rating on the shares. The firm is adjusting its model after the…
AdaptHealth price target raised to $18 from $17 at Baird
Baird analyst Eric Coldwell raised the firm’s price target on AdaptHealth (AHCO) to $18 from $17 and keeps an Outperform rating on the shares. The firm updated its model following…
AdaptHealth price target raised to $16 from $14 at Canaccord
Canaccord raised the firm’s price target on AdaptHealth (AHCO) to $16 from $14 and keeps a Buy rating on the shares. The firm updated its model following Q1 results where…
AdaptHealth price target lowered to $14 from $15 at UBS
UBS lowered the firm’s price target on AdaptHealth (AHCO) to $14 from $15 and keeps a Buy rating on the shares.
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Earnings Call Transcript: Q1 2026
Revenue and organic growth exceeded guidance, driven by a major capitated contract and strong segment performance. Labor and startup costs impacted Q1 margins, but normalization and full contract ramp are expected to boost profitability and cash flow in the coming quarters.
AdaptHealth Earnings release: Q1 2026
AdaptHealth released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
AdaptHealth Slides: Q1 2026
AdaptHealth has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
AdaptHealth Quarterly report: Q1 2026
AdaptHealth has published its Q1 2026 quarterly earnings report on May 5, 2026.
AdaptHealth reports Q1 EPS (12c), consensus 1c
Reports Q1 revenue $819.799M, consensus $796.63M. “The opening months of 2026 have set the stage for what will be a defining year for AdaptHealth (AHCO),” said Suzanne Foster, Chief Executive…
AdaptHealth sees FY26 net revenue $3.45B-$3.52B, consensus $3.47B
For fiscal year 2026, the Company is raising net revenue guidance by $10 million and maintaining Adjusted EBITDA and free cash flow guidance, as follows: Net revenue of $3.45 billion…
AdaptHealth Corp. Announces First Quarter 2026 Results
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Proxy statement: Proxy filing
AdaptHealth filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.